FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Pass VALID Act Now: Former Commissioners

Former FDA commissioners Scott Gottlieb and Mark McClellan call on Congress to promptly pass the VALID Act to modernize FDA regulation of laboratory-d...

latest-news-card-1
Human Drugs

Guide on PK-Based Criteria for PD1/PD-L1 Alt Dosing

FDA posts a final guidance on pharmacokinetic-based criteria used to supporting alternative dosing programmed cell death receptor-1 or programmed cell...

latest-news-card-1
Federal Register

Selective Safety Data Collection Final Guidance

Federal Register notice: FDA makes available a final guidance entitled E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-A...

latest-news-card-1
Human Drugs

Contract Lab Valisure Relinquishes its Testing Prowess

Contract testing laboratory Valisure relinquishes its regulatory testing ability after a recent FDA inspection raised testing issues associated with t...

latest-news-card-1
Medical Devices

FDA Updates Endologix Endovascular Graft Safety

FDA updates a January safety communication about the use of Endologix AFX endovascular grafts for treating patients with abdominal aortic aneurysms.

latest-news-card-1
Human Drugs

Clinical Hold Issues Outlined for Cholesterol Gene Therapy

FDA issues Verve Therapeutics a formal clinical hold letter that outlines the information required to resolve a hold that was placed 11/4 on VERVE-101...

latest-news-card-1
Medical Devices

FDA Confirms Survival Rate With Abiomeds Heart Device

FDA confirms the survival rate of Abiomeds Impella RP System that was required to undergo a post-approval study after being approved in 2017.

Biologics

Firms Seek EUA for Omicron Vaccine in Young Children

Pfizer and BioNTech file an application seeking an emergency use authorization for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine as the th...

latest-news-card-1
Federal Register

Guide on Bioequivalence Statistical Approaches

Federal Register notice: FDA makes available a draft guidance entitled Statistical Approaches to Establishing Bioequivalence.

latest-news-card-1
Human Drugs

Novartis Seeking Expanded Pluvicto Use

Novartis says it will seek FDA approval for an expanded use for Pluvicto (lutetium Lu 177 vipivotide tetraxetan), for slowing disease progression in c...